Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hooman Madyoon

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Cardiology|March 17, 2004
Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial)On Topaz, Douglas Ebersole, Tony Das, et al.
Lasers in Medical Science|April 12, 2007
Excimer laser in myocardial infarction: a comparison between STEMI patients with established Q-wave versus patients with non-STEMI (non-Q), On Topaz, Douglas Ebersole, et al.
JAMA|November 6, 2003
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trialGregg W Stone, Peter A McCullough, James A Tumlin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Cardiology|March 17, 2004
Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial)On Topaz, Douglas Ebersole, Tony Das, et al.
Lasers in Medical Science|April 12, 2007
Excimer laser in myocardial infarction: a comparison between STEMI patients with established Q-wave versus patients with non-STEMI (non-Q), On Topaz, Douglas Ebersole, et al.
JAMA|November 6, 2003
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trialGregg W Stone, Peter A McCullough, James A Tumlin, et al.
Pageof 2